Your browser doesn't support javascript.
loading
Impact of Checkpoint Inhibitor Pneumonitis on Survival in NSCLC Patients Receiving Immune Checkpoint Immunotherapy.
Suresh, Karthik; Psoter, Kevin J; Voong, Khinh Ranh; Shankar, Bairavi; Forde, Patrick M; Ettinger, David S; Marrone, Kristen A; Kelly, Ronan J; Hann, Christine L; Levy, Benjamin; Feliciano, Josephine L; Brahmer, Julie R; Feller-Kopman, David; Lerner, Andrew D; Lee, Hans; Yarmus, Lonny; Hales, Russell K; D'Alessio, Franco; Danoff, Sonye K; Naidoo, Jarushka.
Affiliation
  • Suresh K; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland. Electronic address: ksuresh2@jhmi.edu.
  • Psoter KJ; Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Voong KR; Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Shankar B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Forde PM; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Ettinger DS; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Marrone KA; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Kelly RJ; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Hann CL; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Levy B; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Feliciano JL; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Brahmer JR; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
  • Feller-Kopman D; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Lerner AD; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Lee H; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Yarmus L; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Hales RK; Department of Radiation Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • D'Alessio F; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Danoff SK; Division of Pulmonary Critical Care Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland.
  • Naidoo J; Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University, Baltimore, Maryland.
J Thorac Oncol ; 14(3): 494-502, 2019 03.
Article de En | MEDLINE | ID: mdl-30503891
Sujet(s)
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pneumopathie infectieuse / Carcinome pulmonaire non à petites cellules / Points de contrôle du cycle cellulaire / Antinéoplasiques immunologiques / Immunothérapie / Tumeurs du poumon Type d'étude: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: J Thorac Oncol Année: 2019 Type de document: Article
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Pneumopathie infectieuse / Carcinome pulmonaire non à petites cellules / Points de contrôle du cycle cellulaire / Antinéoplasiques immunologiques / Immunothérapie / Tumeurs du poumon Type d'étude: Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male Pays/Région comme sujet: America do norte Langue: En Journal: J Thorac Oncol Année: 2019 Type de document: Article